Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Testing effectiveness (Phase 2)Study completedNCT00002873What this trial is testingRadiation Therapy in Treating Women With Stage I or Stage II Breast CancerWho this might be right forBreast Cancer Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT03635892What this trial is testingNivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell CarcinomaWho this might be right forAdvanced or Metastatic Non-clear Cell Renal Cell CarcinomaUnclassified Renal Cell CarcinomaPapillary Renal Cell Carcinoma+4 more Memorial Sloan Kettering Cancer Center 60
Not applicableLooking for participantsNCT07117045What this trial is testingArtificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic CancerWho this might be right forPancreatic CancerIntraductal Papillary Mucinous NeoplasmHigh-grade Pancreatic Intraepithelial Neoplasia+2 more Changhai Hospital 400,000
Not applicableStudy completedNCT06051838What this trial is testingPrognostic Value of Tumor Deposits for Patients With Papillary Thyroid CarcinomaWho this might be right forExploring the Prognostic Value of Tumor Deposits PTC Patients Nanfang Hospital, Southern Medical University 541
Testing effectiveness (Phase 2)Ended earlyNCT00447226What this trial is testingRandomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy ExistsWho this might be right forCancer GlaxoSmithKline 32
Not applicableEnded earlyNCT05014698What this trial is testingIDEntification of New Predisposition Genes in Differentiated THYroid CancerWho this might be right forDifferentiated Thyroid CancerThyroid Cancer, Nonmedullary Nantes University Hospital 34
Early research (Phase 1)Study completedNCT00451880What this trial is testingStudy of XL281 in Adults With Solid TumorsWho this might be right forCancerNon-small-cell Lung CancerColorectal Cancer+2 more Exelixis 180
Not applicableLooking for participantsNCT07545837What this trial is testingHealth and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer SurvivorsWho this might be right forThyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma Mayo Clinic 20
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Study completedNCT00381641What this trial is testingSunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryWho this might be right forDifferentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaRefractory Thyroid Gland Carcinoma+16 more National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Study completedNCT00459979What this trial is testingSunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by SurgeryWho this might be right forKidney Cancer Case Comprehensive Cancer Center 30
Early research (Phase 1)Ended earlyNCT02012231What this trial is testingPhase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Who this might be right forMelanomaThyroid CancerColorectal Cancer+4 more Fore Biotherapeutics 5
Large-scale testing (Phase 3)Active Not RecruitingNCT05043090What this trial is testingSavolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCCWho this might be right forPapillary Renal Cell Carcinoma AstraZeneca 148
Not applicableUnknownNCT00984191What this trial is testingPilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) ThyroidWho this might be right forPapillary Thyroid Cancer Chulalongkorn University 15
Not applicableStudy completedNCT00005799What this trial is testingFludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more Fred Hutchinson Cancer Center 55
Large-scale testing (Phase 3)UnknownNCT00415233What this trial is testingHigh Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid CancerWho this might be right forHead and Neck Cancer University College, London 438
Not applicableActive Not RecruitingNCT06271044What this trial is testingA. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESSWho this might be right forto Omit Radioiodine Treatment Safely in Patients With Low -Risk Papillary Thyroid Cancer With Seize of 11-20mm Helsinki University Central Hospital 61
Large-scale testing (Phase 3)Study completedNCT01120249What this trial is testingS0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone SurgeryWho this might be right forKidney Cancer SWOG Cancer Research Network 1,545
Testing effectiveness (Phase 2)Active Not RecruitingNCT00909909What this trial is testingRadiation Therapy in Treating Women With Early Stage Breast CancerWho this might be right forBreast Cancer Rutgers, The State University of New Jersey 200